Triple
T1046885
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ministry of Health and Care Services (Norway) |
E22600
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
Norwegian Medicines Agency
The Norwegian Medicines Agency is Norway’s national regulatory authority responsible for the approval, monitoring, and safe use of medicines and related health products.
|
E119701
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Norwegian Medicines Agency | Statement: [Ministry of Health and Care Services (Norway), oversees, Norwegian Medicines Agency]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Norwegian Medicines Agency Context triple: [Ministry of Health and Care Services (Norway), oversees, Norwegian Medicines Agency]
-
A.
Ministry of Health and Care Services (Norway)
The Ministry of Health and Care Services (Norway) is the national government ministry responsible for public health policy, healthcare services, and social care in Norway.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Norwegian Medicines Agency Triple: [Ministry of Health and Care Services (Norway), oversees, Norwegian Medicines Agency]
Generated description
The Norwegian Medicines Agency is Norway’s national regulatory authority responsible for the approval, monitoring, and safe use of medicines and related health products.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Norwegian Medicines Agency Target entity description: The Norwegian Medicines Agency is Norway’s national regulatory authority responsible for the approval, monitoring, and safe use of medicines and related health products.
-
A.
Ministry of Health and Care Services (Norway)
The Ministry of Health and Care Services (Norway) is the national government ministry responsible for public health policy, healthcare services, and social care in Norway.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a493da02e081908c13ff5e02a0fe7a |
completed | March 1, 2026, 7:30 p.m. |
| NER | Named-entity recognition | batch_69a4b84d30888190b66f7245d781957d |
completed | March 1, 2026, 10:06 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac3bcb65d08190b2ea04b6de3bb39b |
completed | March 7, 2026, 2:52 p.m. |
| NEDg | Description generation | batch_69ac3ce6228881908f429cb0a016a17a |
completed | March 7, 2026, 2:57 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69ac3d3ed140819087ede15c555e2f4d |
completed | March 7, 2026, 2:59 p.m. |
Created at: March 1, 2026, 7:42 p.m.